Info
Insider Ownership

Insider Trading & Ownership of Mark Lackner

Location: South San Francisco, CA
Summary: The estimated net worth of Mark Lackner is at least $877,753 dollars as of 05 Feb 2025. Mark Lackner is the Chief Scientific Officer of Zentalis Pharmaceuticals, Inc. and owns shares of Zentalis Pharmaceuticals, Inc. (ZNTL) stock worth about $877.8K.
Signature: /s/ Andrea Paul, attorney-in-fact for Mark Lackner
All Insider Reports: All Insider Reports

Notify me when Mark Lackner files a new Insider Trading report.

⭐ Subscribe ⭐

Ownership of Mark Lackner

Symbol	Company	Relationship	Holdings Value	Past Year Net Change	Change %	Report Period
ZNTL	Zentalis Pharmaceuticals, Inc.	Chief Scientific Officer	$877,753			03 Feb 2025

Insider Transactions Reported by Mark Lackner:

Sym	Company	Class	Transaction	%	Value $	* Price $	Shares	Shares After	Date	Ownership

* An asterisk sign (*) next to the price indicates that the price is likely invalid.